Deschloroketamine (DXE, DCK, 2'-Oxo-PCM) is a dissociative anesthetic[1][2] that has been sold online as a designer drug.[3][4][5][6][7] It has also been proposed for the treatment of bacterial, fungal, viral or protozoal infections and for immunomodulation at doses of 2 mg per day.[8]
Legal status
Deschloroketamine is illegal in Latvia.[9]
See also
References
- ^ Robins EG, Zhao Y, Khan I, Wilson A, Luthra SK, Rstad E (March 2010). "Synthesis and in vitro evaluation of (18)F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET". Bioorganic & Medicinal Chemistry Letters. 20 (5): 1749–51. doi:10.1016/j.bmcl.2010.01.052. PMID 20138515.
- ^ US 3254124, Stevens CL, "Aminoketones and methods for their production", published 31 May 1966
- ^ Frison G, Zamengo L, Zancanaro F, Tisato F, Traldi P (January 2016). "Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance". Rapid Communications in Mass Spectrometry. 30 (1): 151–60. Bibcode:2016RCMS...30..151F. doi:10.1002/rcm.7425. PMID 26661982.
- ^ "Alerta: descloroketamina vendida como ketamina en Barcelona" (in Spanish). Energy Control. Retrieved 2 October 2015.
- ^ Villalba J (27 March 2015). "Los efectos desconocidos de la sequía de ketamina" (in Spanish). Vice. Retrieved 2 October 2015.
- ^ Knibbs J (22 October 2015). "Party-drug testing shows its worth". The Medical Republic.
- ^ Hájková K, Jurásek B, Čejka J, Štefková K, Páleníček T, Sýkora D, Kuchař M (October 2019). "Synthesis and identification of deschloroketamine metabolites in rats' urine and a quantification method for deschloroketamine and metabolites in rats' serum and brain tissue using liquid chromatography tandem mass spectrometry". Drug Testing and Analysis. 12 (3): 343–360. doi:10.1002/dta.2726. PMID 31670910. S2CID 204975994.
- ^ DE 4409671, Preiss D, Tatar A, "Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, viral or protozoal infections and for immunomodulation", published 23 May 1995
- ^ "Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem" [Regulations on Narcotic Drugs, Psychotropic Substances and Precursors Controlled in Latvia] (in Latvian). Ministry of Health of the Republic of Latvia. Archived from the original on 4 March 2016. Retrieved 29 October 2015.
|
|---|
Psychedelics (5-HT2AR agonists) |
- Tryptamines (e.g., DMT, psilocin, psilocybin, bufotenin, 5-MeO-DMT, AMT)
- Phenethylamines (e.g., mescaline, 2C-B, DOM, MDA, TMA, 2C-B-FLY, 25I-NBOMe)
- Lysergamides (e.g., LSD, ergine, isoergine)
- Others (e.g., quipazine, efavirenz)
- For a full list of serotonergic psychedelics, see the navbox here and the list here instead.
|
|---|
Dissociatives (NMDAR antagonists) | |
|---|
Deliriants (mAChR antagonists) | |
|---|
Cannabinoids (CB1R agonists) | | Natural | |
|---|
| Synthetic | | AM-x |
- AM-087
- AM-251
- AM-279
- AM-281
- AM-356
- AM-374
- AM-381
- AM-404
- AM-411
- AM-630
- AM-661
- AM-678
- AM-679
- AM-694
- AM-735
- AM-855
- AM-881
- AM-883
- AM-905
- AM-906
- AM-919
- AM-926
- AM-938
- AM-1116
- AM-1172
- AM-1220
- AM-1221
- AM-1235
- AM-1241
- AM-1248
- AM-1710
- AM-1714
- AM-1902
- AM-2201
- AM-2212
- AM-2213
- AM-2232
- AM-2233
- AM-2389
- AM-3102
- AM-4030
- AM-4054
- AM-4056
- AM-4113
- AM-6545
|
|---|
| CP x |
- CP 47,497
- CP 55,244
- CP 55,940
- (±)-CP 55,940
- (+)-CP 55,940
- (-)-CP 55,940
|
|---|
| HU-x | |
|---|
| JWH-x | |
|---|
| Misc. | |
|---|
- For a full list of cannabinoids, see the navbox here and the list here instead.
|
|---|
|
|---|
| κOR agonists | |
|---|
| GABAAR agonists | |
|---|
Inhalants (mixed MoATooltip mechanism of action) | |
|---|
| Others |
- Aminochromes (e.g., adrenochrome, adrenolutin)
- Carbogen
- Certain GABAA receptor positive allosteric modulators (nonbenzodiazepines/Z-drugs) (e.g., eszopiclone, zaleplon, zolpidem, zopiclone)
- CI-966
- Cryogenine
- Glaucine
- Hallucinogenic bolete mushrooms (e.g., Lanmaoa asiatica)
- Harmala alkaloids/β-carbolines (e.g., harmaline, 6-methoxyharmalan)
- Iboga alkaloids/azepinoindoles (e.g., ibogaine)
- Isoaminile
- Noscapine
- Nutmeg (e.g., myristicin, elemicin)
- Oneirogens (e.g., Calea zacatechichi, galantamine, nicotine, Silene capensis)
- Prenoxdiazine
- Pukateine
|
|---|
- See also: Psychedelics
- Entactogens
- Stimulants
- Depressants
- List of hallucinogens
|
|
|---|
|
|---|
| AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor | |
|---|
| KARTooltip Kainate receptor | |
|---|
| NMDARTooltip N-Methyl-D-aspartate receptor |
- Unsorted: Allosteric modulators: AGN-241751
|
|---|
- See also: Receptor/signaling modulators
- Metabotropic glutamate receptor modulators
- Glutamate metabolism/transport modulators
|
|
|---|
| Group I | | mGluR1Tooltip Metabotropic glutamate receptor 1 |
- Antagonists: BAY 36-7620
- CPCCOEt
- Cyclothiazide
- LY-367,385
- LY-456,236
- MCPG
- NPS-2390
|
|---|
| mGluR5Tooltip Metabotropic glutamate receptor 5 |
- Antagonists: CTEP
- DMeOB
- LY-344,545
- Mavoglurant
- MCPG
- NPS-2390
- Remeglurant
- SIB-1757
- SIB-1893; Negative allosteric modulators: AZD9272
- Basimglurant
- Dipraglurant
- Fenobam
- GRN-529
- MPEP
- MTEP
- Raseglurant
|
|---|
|
|---|
| Group II | | mGluR2Tooltip Metabotropic glutamate receptor 2 |
- Agonists: BINA
- CBiPES
- DCG-IV
- Eglumegad
- Glutamate
- Ibotenic acid
- LY-379,268
- LY-404,039 (pomaglumetad)
- LY-487,379
- LY-566,332
- MGS-0028
- Pomaglumetad methionil (LY-2140023)
- Talaglumetad; Positive allosteric modulators: JNJ-40411813 (ADX-71149)
- Antagonists: APICA
- CECXG
- EGLU
- HYDIA
- LY-307,452
- LY-341,495
- MCPG
- MGS-0039
- PCCG-4; Negative allosteric modulators: Decoglurant
- RO4491533
|
|---|
| mGluR3Tooltip Metabotropic glutamate receptor 3 |
- Agonists: CBiPES
- DCG-IV
- Eglumegad
- Glutamate
- Ibotenic acid
- LY-379,268
- LY-404,039 (pomaglumetad)
- LY-487,379
- MGS-0028
- Pomaglumetad methionil (LY-2140023)
- Talaglumetad
- Antagonists: APICA
- CECXG
- EGLU
- HYDIA
- LY-307,452
- LY-341,495
- MCPG
- MGS-0039; Negative allosteric modulators: Decoglurant
- RO4491533
|
|---|
|
|---|
| Group III | | mGluR4Tooltip Metabotropic glutamate receptor 4 |
- Agonists: Glutamate
- L-AP4
- LSP2-9166
- PHCCC
- VU-001,171
- VU-0155,041; Positive allosteric modulators: Foliglurax
- MPEP
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR6Tooltip Metabotropic glutamate receptor 6 |
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR7Tooltip Metabotropic glutamate receptor 7 |
- Antagonists: CPPG
- MAP4
- MMPIP
- MPPG
- MSOP
- MTPG
- UBP-1112
- XAP044; Negative allosteric modulators: ADX71743
|
|---|
| mGluR8Tooltip Metabotropic glutamate receptor 8 |
- Agonists: DCPG
- Glutamate
- L-AP4; Positive allosteric modulators: AZ12216052
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
|
|---|
See also: Receptor/signaling modulators • Ionotropic glutamate receptor modulators • Glutamate metabolism/transport modulators |
|